Idiopathic pulmonary fibrosis: state of the art for 2023
The DOI matches its Crossref record; 188 of the 196 references it cites were found in a registry or an index.
Abstract
Review noting that IPF is a progressive fibrotic lung disease characterized by worsening respiratory symptoms and physiological impairment, while the individual patient course and rate of disease progression are often unpredictable and heterogeneous.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Up to now, the specific therapeutic drugs that reverse IPF or halt the progression of IPF are still unavailable due to the incomplete understanding of the pathogenesis of IPF 5.”
From Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice (2024) · cites this paper as [5]
Citations
Cites
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Self-citationEfficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
Self-citationTravis, W. D., Costabel, U., Hansell, D. M., King, T. E., Lynch, D. A., Nicholson, A. G., Ryerson, C. J., Ryu, J. H., Selman, M., Wells, A. U., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1483st · Cited by 4,290
Self-citation(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Raghu, G., Remy-Jardin, M., Myers, J. L., Richeldi, L., Ryerson, C. J., Lederer, D. J., Behr, J., Cottin, V., Danoff, S. K., Morell, F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1255st · Cited by 4,103
Self-citationA phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Raghu, G., Remy-Jardin, M., Richeldi, L., Thomson, C. C., Inoue, Y., Johkoh, T., Kreuter, M., Lynch, D. A., Maher, T. M., Martinez, F. J., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202202-0399st · Cited by 2,957
Self-citationIdiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Lederer, D. J., & Martinez, F. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1705751 · Cited by 2,056
Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916
Self-citationClinical course and prediction of survival in idiopathic pulmonary fibrosis
Ley, B., Collard, H. R., & King, T. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0894ci · Cited by 1,765
Prednisone, Azathioprine, and N -Acetylcysteine for Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis Clinical Research Network (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113354 · Cited by 1,621
Blackburn, E. H., Epel, E. S., & Lin, J. (2015) · Science · doi:10.1126/science.aab3389 · Cited by 1,596
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report
Collard, H. R., Ryerson, C. J., Corte, T. J., Jenkins, G., Kondoh, Y., Lederer, D. J., Lee, J. S., Maher, T. M., Wells, A. U., Antoniou, K. M., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0801ci · Cited by 1,444
Self-citationTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310
Self-citationA Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis
Seibold, M. A., Wise, A. L., Speer, M. C., Steele, M. P., Brown, K. K., Loyd, J. E., Fingerlin, T. E., Zhang, W., Gudmundsson, G., Groshong, S. D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013660 · Cited by 1,198
Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Collard, H. R., Moore, B. B., Flaherty, K. R., Brown, K. K., Kaner, R. J., King, T. E., Lasky, J. A., Loyd, J. E., Noth, I., Olman, M. A., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-463pp · Cited by 1,130
Self-citationRaghu, G., Remy-Jardin, M., Ryerson, C. J., Myers, J. L., Kreuter, M., Vasakova, M., Bargagli, E., Chung, J. H., Collins, B. F., Bendstrup, E., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202005-2032st · Cited by 1,047
Self-citationDiagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper
Lynch, D. A., Sverzellati, N., Travis, W. D., Brown, K. K., Colby, T. V., Galvin, J. R., Goldin, J. G., Hansell, D. M., Inoue, Y., Johkoh, T., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30433-2 · Cited by 1,030
Self-citationCombined pulmonary fibrosis and emphysema: a distinct underrecognised entity
Cottin, V., Nunes, H., Brillet, P.-Y., Delaval, P., Devouassoux, G., Tillie-Leblond, I., Israel-Biet, D., Court-Fortune, I., Valeyre, D., & Cordier, J.-F. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00021005 · Cited by 1,004
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
Hutchinson, J., Fogarty, A., Hubbard, R., & McKeever, T. (2015) · European Respiratory Journal · doi:10.1183/09031936.00185114 · Cited by 913
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Lettieri, C. J., Nathan, S. D., Barnett, S. D., Ahmad, S., & Shorr, A. F. (2006) · Chest · doi:10.1378/chest.129.3.746 · Cited by 879
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis
Fingerlin, T. E., Murphy, E., Zhang, W., Peljto, A. L., Brown, K. K., Steele, M. P., Loyd, J. E., Cosgrove, G. P., Lynch, D., Groshong, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2609 · Cited by 809
Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Alder, J. K., Chen, J. J.-L., Lancaster, L., Danoff, S., Su, S.-C., Cogan, J. D., Vulto, I., Xie, M., Qi, X., Tuder, R. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804280105 · Cited by 805
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
Song, J. W., Hong, S.-B., Lim, C.-M., Koh, Y., & Kim, D. S. (2011) · European Respiratory Journal · doi:10.1183/09031936.00159709 · Cited by 783
Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis.
Baumgartner, K. B., Samet, J. M., Stidley, C. A., Colby, T. V., & Waldron, J. A. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.1.9001319 · Cited by 767
Spectrum of fibrotic lung diseases
Wijsenbeek, M., & Cottin, V. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2005230 · Cited by 736
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
King, T. E., Brown, K. K., Raghu, G., du Bois, R. M., Lynch, D. A., Martinez, F., Valeyre, D., Leconte, I., Morganti, A., Roux, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1874oc · Cited by 718
Self-citationRaghu, G., Chen, S.-Y., Yeh, W.-S., Maroni, B., Li, Q., Lee, Y.-C., & Collard, H. R. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70101-8 · Cited by 716
Self-citationWells, A. U., Desai, S. R., Rubens, M. B., Goh, N. S. L., Cramer, D., Nicholson, A. G., Colby, T. V., du Bois, R. M., & Hansell, D. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2111053 · Cited by 686
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
Waxman, A., Restrepo-Jaramillo, R., Thenappan, T., Ravichandran, A., Engel, P., Bajwa, A., Allen, R., Feldman, J., Argula, R., Smith, P., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2008470 · Cited by 666
Thomas, A. Q., Lane, K., Phillips, J., Prince, M., Markin, C., Speer, M., Schwartz, D. A., Gaddipati, R., Marney, A., Johnson, J., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200112-123oc · Cited by 641
A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002110 · Cited by 634
Noth, I., Zhang, Y., Ma, S.-F., Flores, C., Barber, M., Huang, Y., Broderick, S. M., Wade, M. S., Hysi, P., Scuirba, J., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70045-6 · Cited by 614
Self-citationGlobal incidence and prevalence of idiopathic pulmonary fibrosis
Maher, T. M., Bendstrup, E., Dron, L., Langley, J., Smith, G., Khalid, J. M., Patel, H., & Kreuter, M. (2021) · Respiratory Research · doi:10.1186/s12931-021-01791-z · Cited by 612
Hatabu, H., Hunninghake, G. M., Richeldi, L., Brown, K. K., Wells, A. U., Remy-Jardin, M., Verschakelen, J., Nicholson, A. G., Beasley, M. B., Christiani, D. C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30168-5 · Cited by 591
Self-citationIncidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK
Gribbin, J., Hubbard, R. B., Le Jeune, I., Smith, C. J. P., West, J., & Tata, L. J. (2006) · Thorax · doi:10.1136/thx.2006.062836 · Cited by 576
Telomere Shortening in Familial and Sporadic Pulmonary Fibrosis
Cronkhite, J. T., Xing, C., Raghu, G., Chin, K. M., Torres, F., Rosenblatt, R. L., & Kim Garcia, C. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-550oc · Cited by 573
Self-citationIncreased Prevalence of Gastroesophageal Reflux in Patients with Idiopathic Pulmonary Fibrosis
TOBIN, R. W., POPE, C. E., PELLEGRINI, C. A., EMOND, M. J., SILLERY, J., & RAGHU, G. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.6.9804105 · Cited by 570
Self-citationThe role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
Molyneaux, P. L., Cox, M. J., Willis-Owen, S. A. G., Mallia, P., Russell, K. E., Russell, A.-M., Murphy, E., Johnston, S. L., Schwartz, D. A., Wells, A. U., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201403-0541oc · Cited by 567
Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan: A Parallel, Randomized Trial
Raghu, G., Behr, J., Brown, K. K., Egan, J. J., Kawut, S. M., Flaherty, K. R., Martinez, F. J., Nathan, S. D., Wells, A. U., Collard, H. R., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-9-201305070-00003 · Cited by 553
Self-citationWijsenbeek, M., Suzuki, A., & Maher, T. M. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01052-2 · Cited by 539
Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis
Fernández Pérez, E. R., Daniels, C. E., St. Sauver, J., Hartman, T. E., Bartholmai, B. J., Yi, E. S., Ryu, J. H., & Schroeder, D. R. (2010) · Chest · doi:10.1378/chest.09-1002 · Cited by 509
Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features
Kim, D. S., Park, J. H., Park, B. K., Lee, J. S., Nicholson, A. G., & Colby, T. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00114004 · Cited by 497
Genetic Defects in Surfactant Protein A2 Are Associated with Pulmonary Fibrosis and Lung Cancer
Wang, Y., Kuan, P. J., Xing, C., Cronkhite, J. T., Torres, F., Rosenblatt, R. L., DiMaio, J. M., Kinch, L. N., Grishin, N. V., & Garcia, C. K. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.11.010 · Cited by 496
The rising incidence of idiopathic pulmonary fibrosis in the UK
Navaratnam, V., Fleming, K. M., West, J., Smith, C. J. P., Jenkins, R. G., Fogarty, A., & Hubbard, R. B. (2011) · Thorax · doi:10.1136/thx.2010.148031 · Cited by 484
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
Cottin, V., Le Pavec, J., Prévot, G., Mal, H., Humbert, M., Simonneau, G., Cordier, J.-F., & GERM“O”P (2010) · European Respiratory Journal · doi:10.1183/09031936.00038709 · Cited by 478
Stuart, B. D., Choi, J., Zaidi, S., Xing, C., Holohan, B., Chen, R., Choi, M., Dharwadkar, P., Torres, F., Girod, C. E., et al. (2015) · Nature Genetics · doi:10.1038/ng.3278 · Cited by 469
Idiopathic Pulmonary Fibrosis and Emphysema
Mejía, M., Carrillo, G., Rojas-Serrano, J., Estrada, A., Suárez, T., Alonso, D., Barrientos, E., Gaxiola, M., Navarro, C., & Selman, M. (2009) · Chest · doi:10.1378/chest.08-2306 · Cited by 468
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
Raghu, G., Amatto, V. C., Behr, J., & Stowasser, S. (2015) · European Respiratory Journal · doi:10.1183/13993003.02316-2014 · Cited by 463
Self-citationMortality from Pulmonary Fibrosis Increased in the United States from 1992 to 2003
Olson, A. L., Swigris, J. J., Lezotte, D. C., Norris, J. M., Wilson, C. G., & Brown, K. K. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-044oc · Cited by 435
Pulmonary Hypertension in Patients With Idiopathic Pulmonary Fibrosis
Nadrous, H. F., Pellikka, P. A., Krowka, M. J., Swanson, K. L., Chaowalit, N., Decker, P. A., & Ryu, J. H. (2005) · Chest · doi:10.1378/chest.128.4.2393 · Cited by 427
Lee, J. S., Collard, H. R., Anstrom, K. J., Martinez, F. J., Noth, I., Roberts, R. S., Yow, E., & Raghu, G. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70105-x · Cited by 413
Self-citationBaumgartner, K. B., Samet, J. M., Coultas, D. B., Stidley, C. A., Hunt, W. C., Colby, T. V., Waldron, J. A., & Centers, C. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.4.307 · Cited by 374
Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New Millennium
Nathan, S. D., Shlobin, O. A., Weir, N., Ahmad, S., Kaldjob, J. M., Battle, E., Sheridan, M. J., & du Bois, R. M. (2011) · Chest · doi:10.1378/chest.10-2572 · Cited by 369
Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis
O’Dwyer, D. N., Ashley, S. L., Gurczynski, S. J., Xia, M., Wilke, C., Falkowski, N. R., Norman, K. C., Arnold, K. B., Huffnagle, G. B., Salisbury, M. L., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201809-1650oc · Cited by 366
Self-citationImpact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis
Kreuter, M., Ehlers-Tenenbaum, S., Palmowski, K., Bruhwyler, J., Oltmanns, U., Muley, T., Heussel, C. P., Warth, A., Kolb, M., & Herth, F. J. F. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151425 · Cited by 351
Self-citationOldham, J. M., Ma, S.-F., Martinez, F. J., Anstrom, K. J., Raghu, G., Schwartz, D. A., Valenzi, E., Witt, L., Lee, C., Vij, R., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-1010oc · Cited by 341
Self-citationHerazo-Maya, J. D., Noth, I., Duncan, S. R., Kim, S., Ma, S.-F., Tseng, G. C., Feingold, E., Juan-Guardela, B. M., Richards, T. J., Lussier, Y., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005964 · Cited by 325
Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis
Hubbard, R., Lewis, S., Richards, K., Johnston, I., & Britton, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90465-1 · Cited by 318
Jacobs, S. S., Krishnan, J. A., Lederer, D. J., Ghazipura, M., Hossain, T., Tan, A.-Y. M., Carlin, B., Drummond, M. B., Ekström, M., Garvey, C., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3608st · Cited by 318
Delayed Access and Survival in Idiopathic Pulmonary Fibrosis: A Cohort Study
Lamas, D. J., Kawut, S. M., Bagiella, E., Philip, N., Arcasoy, S. M., & Lederer, D. J. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0668oc · Cited by 314
The Impact of Lung Cancer on Survival of Idiopathic Pulmonary Fibrosis
Tomassetti, S., Gurioli, C., Ryu, J. H., Decker, P. A., Ravaglia, C., Tantalocco, P., Buccioli, M., Piciucchi, S., Sverzellati, N., Dubini, A., et al. (2015) · Chest · doi:10.1378/chest.14-0359 · Cited by 314
Stuart, B. D., Lee, J. S., Kozlitina, J., Noth, I., Devine, M. S., Glazer, C. S., Torres, F., Kaza, V., Girod, C. E., Jones, K. D., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70124-9 · Cited by 310
Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris
Duchemann, B., Annesi-Maesano, I., Jacobe de Naurois, C., Sanyal, S., Brillet, P.-Y., Brauner, M., Kambouchner, M., Huynh, S., Naccache, J. M., Borie, R., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02419-2016 · Cited by 304
Allen, R. J., Porte, J., Braybrooke, R., Flores, C., Fingerlin, T. E., Oldham, J. M., Guillen-Guio, B., Ma, S.-F., Okamoto, T., John, A. E., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30387-9 · Cited by 297
Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure
Johannson, K. A., Vittinghoff, E., Lee, K., Balmes, J. R., Ji, W., Kaplan, G. G., Kim, D. S., & Collard, H. R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00122213 · Cited by 295
Patel, A. S., Siegert, R. J., Brignall, K., Gordon, P., Steer, S., Desai, S. R., Maher, T. M., Renzoni, E. A., Wells, A. U., Higginson, I. J., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-201581 · Cited by 290
Viral Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Wootton, S. C., Kim, D. S., Kondoh, Y., Chen, E., Lee, J. S., Song, J. W., Huh, J. W., Taniguchi, H., Chiu, C., Boushey, H., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201010-1752oc · Cited by 285
Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial
Raghu, G., Million-Rousseau, R., Morganti, A., Perchenet, L., Behr, J., & the MUSIC Study Group (2013) · European Respiratory Journal · doi:10.1183/09031936.00104612 · Cited by 277
Self-citationGenetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF
Lawson, W. E. (2004) · Thorax · doi:10.1136/thx.2004.026336 · Cited by 272
Maher, T. M., Oballa, E., Simpson, J. K., Porte, J., Habgood, A., Fahy, W. A., Flynn, A., Molyneaux, P. L., Braybrooke, R., Divyateja, H., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30430-7 · Cited by 271
Guenther, A., Krauss, E., Tello, S., Wagner, J., Paul, B., Kuhn, S., Maurer, O., Heinemann, S., Costabel, U., Barbero, M. A. N., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0845-5 · Cited by 268
Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis
Kolb, M., Raghu, G., Wells, A. U., Behr, J., Richeldi, L., Schinzel, B., Quaresma, M., Stowasser, S., & Martinez, F. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1811737 · Cited by 264
Self-citationNathan, S. D., Behr, J., Collard, H. R., Cottin, V., Hoeper, M. M., Martinez, F. J., Corte, T. J., Keogh, A. M., Leuchte, H., Mogulkoc, N., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30250-4 · Cited by 253
Self-citationPulmonary Hypertension in Idiopathic Pulmonary Fibrosis
Patel, N. M., Lederer, D. J., Borczuk, A. C., & Kawut, S. M. (2007) · Chest · doi:10.1378/chest.06-3087 · Cited by 248
An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis
Petrovski, S., Todd, J. L., Durheim, M. T., Wang, Q., Chien, J. W., Kelly, F. L., Frankel, C., Mebane, C. M., Ren, Z., Bridgers, J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201610-2088oc · Cited by 242
Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis
Lee, J. S., Song, J. W., Wolters, P. J., Elicker, B. M., King, T. E., Kim, D. S., & Collard, H. R. (2012) · European Respiratory Journal · doi:10.1183/09031936.00050911 · Cited by 241
Scott, M. K. D., Quinn, K., Li, Q., Carroll, R., Warsinske, H., Vallania, F., Chen, S., Carns, M. A., Aren, K., Sun, J., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30508-3 · Cited by 237
Self-citationComputed Tomography Findings in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Akira, M., Kozuka, T., Yamamoto, S., & Sakatani, M. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1365oc · Cited by 233
Jo, H. E., Glaspole, I., Grainge, C., Goh, N., Hopkins, P. M. A., Moodley, Y., Reynolds, P. N., Chapman, S., Walters, E. H., Zappala, C., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01592-2016 · Cited by 233
Incidence, Prevalence, and Survival of Patients with Idiopathic Pulmonary Fibrosis in the UK
Strongman, H., Kausar, I., & Maher, T. M. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0693-1 · Cited by 233
Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice
Hancock, L. A., Hennessy, C. E., Solomon, G. M., Dobrinskikh, E., Estrella, A., Hara, N., Hill, D. B., Kissner, W. J., Markovetz, M. R., Grove Villalon, D. E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07768-9 · Cited by 233
Han, M. K., Bach, D. S., Hagan, P. G., Yow, E., Flaherty, K. R., Toews, G. B., Anstrom, K. J., & Martinez, F. J. (2013) · Chest · doi:10.1378/chest.12-1594 · Cited by 227
Self-citationRyerson, C. J., Corte, T. J., Lee, J. S., Richeldi, L., Walsh, S. L. F., Myers, J. L., Behr, J., Cottin, V., Danoff, S. K., Flaherty, K. R., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201702-0400pp · Cited by 226
Self-citationDrake, T. M., Docherty, A. B., Harrison, E. M., Quint, J. K., Adamali, H., Agnew, S., Babu, S., Barber, C. M., Barratt, S., Bendstrup, E., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202007-2794oc · Cited by 226
Cottin, V., Selman, M., Inoue, Y., Wong, A. W., Corte, T. J., Flaherty, K. R., Han, M. K., Jacob, J., Johannson, K. A., Kitaichi, M., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202206-1041st · Cited by 226
Self-citationImpact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis
Petnak, T., Lertjitbanjong, P., Thongprayoon, C., & Moua, T. (2021) · Chest · doi:10.1016/j.chest.2021.06.049 · Cited by 220
Kenmotsu, H., Naito, T., Kimura, M., Ono, A., Shukuya, T., Nakamura, Y., Tsuya, A., Kaira, K., Murakami, H., Takahashi, T., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318216ee6b · Cited by 217
Host–Microbial Interactions in Idiopathic Pulmonary Fibrosis
Molyneaux, P. L., Willis-Owen, S. A. G., Cox, M. J., James, P., Cowman, S., Loebinger, M., Blanchard, A., Edwards, L. M., Stock, C., Daccord, C., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201607-1408oc · Cited by 217
Increasing Global Mortality from Idiopathic Pulmonary Fibrosis in the Twenty-First Century
Hutchinson, J. P., McKeever, T. M., Fogarty, A. W., Navaratnam, V., & Hubbard, R. B. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201404-145oc · Cited by 214
Lancaster, L., Crestani, B., Hernandez, P., Inoue, Y., Wachtlin, D., Loaiza, L., Quaresma, M., Stowasser, S., & Richeldi, L. (2019) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2018-000397 · Cited by 209
Self-citationBarriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey
Cosgrove, G. P., Bianchi, P., Danese, S., & Lederer, D. J. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0560-x · Cited by 208
Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis
Sheng, G., Chen, P., Wei, Y., Yue, H., Chu, J., Zhao, J., Wang, Y., Zhang, W., & Zhang, H.-L. (2020) · Chest · doi:10.1016/j.chest.2019.10.032 · Cited by 208
Collard, H. R., Yow, E., Richeldi, L., Anstrom, K. J., Glazer, C., & for the IPFnet investigators (2013) · Respiratory Research · doi:10.1186/1465-9921-14-73 · Cited by 207
Self-citationPirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis
Ley, B., Swigris, J., Day, B.-M., Stauffer, J. L., Raimundo, K., Chou, W., & Collard, H. R. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0091oc · Cited by 206
Behr, J., Prasse, A., Wirtz, H., Koschel, D., Pittrow, D., Held, M., Klotsche, J., Andreas, S., Claussen, M., Grohé, C., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.02279-2019 · Cited by 198
Dressen, A., Abbas, A. R., Cabanski, C., Reeder, J., Ramalingam, T. R., Neighbors, M., Bhangale, T. R., Brauer, M. J., Hunkapiller, J., Reeder, J., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30135-8 · Cited by 196
The genetic basis of idiopathic pulmonary fibrosis
Kropski, J. A., Blackwell, T. S., & Loyd, J. E. (2015) · European Respiratory Journal · doi:10.1183/09031936.00163814 · Cited by 193
Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis
García-Sancho, C., Buendía-Roldán, I., Fernández-Plata, M. R., Navarro, C., Pérez-Padilla, R., Vargas, M. H., Loyd, J. E., & Selman, M. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.08.022 · Cited by 189
Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis
Kreuter, M., Lee, J. S., Tzouvelekis, A., Oldham, J. M., Molyneaux, P. L., Weycker, D., Atwood, M., Kirchgaessler, K.-U., & Maher, T. M. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0669oc · Cited by 187
Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada
Hopkins, R. B., Burke, N., Fell, C., Dion, G., & Kolb, M. (2016) · European Respiratory Journal · doi:10.1183/13993003.01504-2015 · Cited by 181
Self-citationWhite, E. S., Xia, M., Murray, S., Dyal, R., Flaherty, C. M., Flaherty, K. R., Moore, B. B., Cheng, L., Doyle, T. J., Villalba, J., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-0862oc · Cited by 180
Kropski, J. A., Pritchett, J. M., Zoz, D. F., Crossno, P. F., Markin, C., Garnett, E. T., Degryse, A. L., Mitchell, D. B., Polosukhin, V. V., Rickman, O. B., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201406-1162oc · Cited by 178
Ryerson, C. J., Cayou, C., Topp, F., Hilling, L., Camp, P. G., Wilcox, P. G., Khalil, N., Collard, H. R., & Garvey, C. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2013.11.016 · Cited by 174
Acute exacerbation of interstitial pneumonia following surgical lung biopsy
Kondoh, Y., Taniguchi, H., Kitaichi, M., Yokoi, T., Johkoh, T., Oishi, T., Kimura, T., Nishiyama, O., Kato, K., & du Bois, R. M. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.02.002 · Cited by 173
Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis
Newton, C. A., Zhang, D., Oldham, J. M., Kozlitina, J., Ma, S.-F., Martinez, F. J., Raghu, G., Noth, I., & Garcia, C. K. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201809-1646oc · Cited by 173
Self-citationPulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction
Raghu, G., Nathan, S. D., Behr, J., Brown, K. K., Egan, J. J., Kawut, S. M., Flaherty, K. R., Martinez, F. J., Wells, A. U., Shao, L., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01537-2014 · Cited by 163
Self-citationEarly diagnosis of fibrotic interstitial lung disease: challenges and opportunities
Spagnolo, P., Ryerson, C. J., Putman, R. K., Oldham, J. M., Salisbury, M. L., Sverzellati, N., Valenzuela, C., Guler, S. A., Jones, S., Wijsenbeek, M. S., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00017-5 · Cited by 163
Raghu, G., Flaherty, K. R., Lederer, D. J., Lynch, D. A., Colby, T. V., Myers, J. L., Groshong, S. D., Larsen, B. T., Chung, J. H., Steele, M. P., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30059-1 · Cited by 157
Self-citationEsposito, D. B., Lanes, S., Donneyong, M., Holick, C. N., Lasky, J. A., Lederer, D., Nathan, S. D., O’Quinn, S., Parker, J., & Tran, T. N. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0818oc · Cited by 151
Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?
Watanabe, A., Higami, T., Ohori, S., Koyanagi, T., Nakashima, S., & Mawatari, T. (2008) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2008.07.016 · Cited by 151
Kim, S. Y., Diggans, J., Pankratz, D., Huang, J., Pagan, M., Sindy, N., Tom, E., Anderson, J. D., Choi, Y., Lynch, D. A., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00140-x · Cited by 148
Self-citationConti, S., Harari, S., Caminati, A., Zanobetti, A., Schwartz, J. D., Bertazzi, P. A., Cesana, G., & Madotto, F. (2018) · European Respiratory Journal · doi:10.1183/13993003.00397-2017 · Cited by 147
Acute Exacerbation of Idiopathic Pulmonary Fibrosis: Outcome and Prognostic Factors
Simon-Blancal, V., Freynet, O., Nunes, H., Bouvry, D., Naggara, N., Brillet, P.-Y., Denis, D., Cohen, Y., Vincent, F., Valeyre, D., et al. (2012) · Respiration · doi:10.1159/000329891 · Cited by 146
Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years
Raghu, G. (2017) · European Respiratory Journal · doi:10.1183/13993003.01209-2017 · Cited by 146
Self-citationRaghu, G., Pellegrini, C. A., Yow, E., Flaherty, K. R., Meyer, K., Noth, I., Scholand, M. B., Cello, J., Ho, L. A., Pipavath, S., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30301-1 · Cited by 144
Self-citationEsposito, A. J., Menon, A. A., Ghosh, A. J., Putman, R. K., Fredenburgh, L. E., El-Chemaly, S. Y., Goldberg, H. J., Baron, R. M., Hunninghake, G. M., & Doyle, T. J. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202006-2441le · Cited by 142
Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis
Collard, H. R., Richeldi, L., Kim, D. S., Taniguchi, H., Tschoepe, I., Luisetti, M., Roman, J., Tino, G., Schlenker-Herceg, R., Hallmann, C., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01339-2016 · Cited by 138
Self-citationBehr, J., Nathan, S. D., Wuyts, W. A., Mogulkoc Bishop, N., Bouros, D. E., Antoniou, K., Guiot, J., Kramer, M. R., Kirchgaessler, K.-U., Bengus, M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30356-8 · Cited by 134
Goobie, G. C., Carlsten, C., Johannson, K. A., Khalil, N., Marcoux, V. S., Assayag, D., Manganas, H., Fisher, J. H., Kolb, M. R. J., Lindell, K. O., et al. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.4696 · Cited by 133
Self-citationNaccache, J.-M., Jouneau, S., Didier, M., Borie, R., Cachanado, M., Bourdin, A., Reynaud-Gaubert, M., Bonniaud, P., Israël-Biet, D., Prévot, G., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00354-4 · Cited by 121
HUIE, T. J., OLSON, A. L., COSGROVE, G. P., JANSSEN, W. J., LARA, A. R., LYNCH, D. A., GROSHONG, S. D., MOSS, M., SCHWARZ, M. I., BROWN, K. K., et al. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01774.x · Cited by 119
Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
Hunninghake, G. M., Quesada-Arias, L. D., Carmichael, N. E., Manzano, J. M. M., Poli, S., Baumgartner, M. A., DiGianni, L. M., Gampala-Sagar, S., Leone, D. A., Gulati, S., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1571oc · Cited by 119
Neighbors, M., Cabanski, C. R., Ramalingam, T. R., Sheng, X. R., Tew, G. W., Gu, C., Jia, G., Peng, K., Ray, J. M., Ley, B., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30185-1 · Cited by 115
Maher, T. M., Stowasser, S., Nishioka, Y., White, E. S., Cottin, V., Noth, I., Selman, M., Rohr, K. B., Michael, A., Ittrich, C., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30255-3 · Cited by 106
Obstructive sleep apnoea and related comorbidities in incident idiopathic pulmonary fibrosis
Gille, T., Didier, M., Boubaya, M., Moya, L., Sutton, A., Carton, Z., Baran‐Marszak, F., Sadoun-Danino, D., Israël‐Biet, D., Cottin, V., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01934-2016 · Cited by 105
Salisbury, M. L., Hewlett, J. C., Ding, G., Markin, C. R., Douglas, K., Mason, W., Guttentag, A., Phillips, J. A., Cogan, J. D., Reiss, S., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201909-1834oc · Cited by 105
Marshall, D. C., Salciccioli, J. D., Shea, B. S., & Akuthota, P. (2018) · European Respiratory Journal · doi:10.1183/13993003.01603-2017 · Cited by 100
Aronson, K. I., Danoff, S. K., Russell, A.-M., Ryerson, C. J., Suzuki, A., Wijsenbeek, M. S., Bajwah, S., Bianchi, P., Corte, T. J., Lee, J. S., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202105-1193st · Cited by 99
Self-citationLung transplantation for interstitial lung disease
Kapnadak, S. G., & Raghu, G. (2021) · European Respiratory Review · doi:10.1183/16000617.0017-2021 · Cited by 91
Self-citationPirfenidone improves survival in IPF: results from a real-life study
Margaritopoulos, G. A., Trachalaki, A., Wells, A. U., Vasarmidi, E., Bibaki, E., Papastratigakis, G., Detorakis, S., Tzanakis, N., & Antoniou, K. M. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0736-z · Cited by 87
Kondoh, Y., Azuma, A., Inoue, Y., Ogura, T., Sakamoto, S., Tsushima, K., Johkoh, T., Fujimoto, K., Ichikado, K., Matsuzawa, Y., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201909-1818oc · Cited by 87
Biomarker signatures for progressive idiopathic pulmonary fibrosis
Clynick, B., Corte, T. J., Jo, H. E., Stewart, I., Glaspole, I. N., Grainge, C., Maher, T. M., Navaratnam, V., Hubbard, R., Hopkins, P. M. A., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01181-2021 · Cited by 86
Idiopathic pulmonary fibrosis in Taiwan – A population-based study
Lai, C., Wang, C., Lu, H.-M., Chen, L., Teng, N.-C., Yan, Y., Wang, J.-Y., Chang, Y.-T., Chao, T.-T., Lin, H.-I., et al. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.07.012 · Cited by 80
Abramson, M. J., Murambadoro, T., Alif, S. M., Benke, G. P., Dharmage, S. C., Glaspole, I., Hopkins, P., Hoy, R. F., Klebe, S., Moodley, Y., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2019-214478 · Cited by 80
Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis
Walsh, S. L. F., Lederer, D. J., Ryerson, C. J., Kolb, M. R. J., Maher, T. M., Nusser, R., Poletti, V. E., Richeldi, L., Vancheri, C., WILSHER, M. L., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0493oc · Cited by 79
Self-citationCorticosteroid use is not associated with improved outcomes in acute exacerbation of IPF
Farrand, E. D., Vittinghoff, E., Ley, B., Butte, A. J., & Collard, H. R. (2019) · Respirology · doi:10.1111/resp.13753 · Cited by 78
Epidemiology of Idiopathic Pulmonary Fibrosis among U.S. Veterans, 2010–2019
Kaul, B., Lee, J. S., Zhang, N., Vittinghoff, E., Sarmiento, K., Collard, H. R., & Whooley, M. A. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202103-295oc · Cited by 78
Karampitsakos, Τ., Torrisi, S. E., Antoniou, K. M., Manali, E. D., Korbila, I. P., Παπαϊωάννου, Ο., Sampsonas, F., Katsaras, M., Vasarmidi, E., Papakosta, D., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01725-9 · Cited by 73
Zhang, D., & Newton, C. A. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.06.037 · Cited by 72
Adegunsoye, A., Oldham, J. M., Bonham, C. A., Hrusch, C. L., Nolan, P., Klejch, W. J., Bellam, S. K., Mehta, U. K., Thakrar, K. H., Pugashetti, J. V., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201804-0761oc · Cited by 71
Racial and Ethnic Disparities in Idiopathic Pulmonary Fibrosis: A UNOS/OPTN Database Analysis
Lederer, D. J., Arcasoy, S. M., Barr, R. G., Wilt, J. S., Bagiella, E., D'Ovidio, F., Sonett, J. R., & Kawut, S. M. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01480.x · Cited by 70
Cutting, C. C., Bowman, W. S., Đao, N. H., Pugashetti, J. V., Garcia, C. K., Oldham, J. M., & Newton, C. A. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.01.026 · Cited by 70
Diagnostic test interpretation and referral delay in patients with interstitial lung disease
Pritchard, D., Adegunsoye, A., LaFond, E., Pugashetti, J. V., Geronimo, R. D., Boctor, N., Sarma, N., Pan, I., Strek, M. E., Kadoch, M. A., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-1228-2 · Cited by 68
Lindell, K. O., Klein, S. J., Veatch, M. S., Gibson, K. F., Kass, D. J., Nouraie, M. S., & Rosenzweig, M. Q. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202012-1494oc · Cited by 67
Timing of onset of symptoms in people with idiopathic pulmonary fibrosis
Hewson, T., McKeever, T. M., Gibson, J., Navaratnam, V. V., Hubbard, R., & Hutchinson, J. P. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210177 · Cited by 66
Behr, J., Kolb, M. R. J., Song, J. W., Luppi, F., Schinzel, B., Stowasser, S., Quaresma, M., & Martínez, F. J. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0488oc · Cited by 64
Self-citationMarinescu, D.-C., Raghu, G., Rémy‐Jardin, M., Travis, W. D., Adegunsoye, A., Beasley, M. B., Chung, J. H., Churg, A., Cottin, V., Egashira, R., et al. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.06.013 · Cited by 61
Self-citationNeighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung Disease
Goobie, G. C., Ryerson, C. J., Johannson, K. A., Schikowski, E., Zou, R. H., Khalil, N., Marcoux, V. S., Assayag, D., Manganas, H., Fisher, J. H., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202109-2065oc · Cited by 60
Self-citationRaghu, G., Remy-Jardin, M., Myers, J., Richeldi, L., & Wilson, K. C. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201907-1324ed · Cited by 59
Self-citationPatolia, S., Kakazu, M. T., Chami, H. A., et al. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202005-420oc · Cited by 58
Self-citationIncidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease
Khor, Y. H., Gutman, L., Hussein, N. S. A., Johannson, K. A., Glaspole, I., Guler, S. A., Funke-Chambour, M., Geiser, T., Goh, N. S. L., & Ryerson, C. J. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.04.037 · Cited by 57
Khan, F. A., Stewart, I., Saini, G., Robinson, K. A., & Jenkins, R. G. (2022) · European Respiratory Journal · doi:10.1183/13993003.01612-2021 · Cited by 57
Molyneaux, P. L., Fahy, W. A., Byrne, A. J., Braybrooke, R., Saunders, P., Toshner, R., Albers, G. J., Chua, F., Renzoni, E. A., Wells, A. U., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202107-1769oc · Cited by 56
Florian, J., Watte, G., Teixeira, P. J. Z., Altmayer, S., Schio, S. M., Sanchez, L. B., Nascimento, D. Z., Camargo, S. M., Perin, F. A., Camargo, J. D. J. P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45828-2 · Cited by 55
Trends in Idiopathic Pulmonary Fibrosis–related Mortality in the United States: 2000–2017
Dove, E. P., Olson, A. L., & Glassberg, M. K. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201905-0958le · Cited by 54
Patient gender bias on the diagnosis of idiopathic pulmonary fibrosis
Assayag, D., Morisset, J., Johannson, K. A., Wells, A. U., & Walsh, S. L. F. (2020) · Thorax · doi:10.1136/thoraxjnl-2019-213968 · Cited by 54
Suspected Interstitial Lung Disease in COPDGene Study
Rose, J. A., Menon, A. A., Hino, T., Hata, A., Nishino, M., Lynch, D. A., Rosas, I. O., El‐Chemaly, S., Raby, B. A., Ash, S. Y., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202203-0550oc · Cited by 53
Postoperative Acute Exacerbation of IPF after Lung Resection for Primary Lung Cancer
Watanabe, A., Kawaharada, N., & Higami, T. (2011) · Pulmonary Medicine · doi:10.1155/2011/960316 · Cited by 52
Khor, Y. H., Bissell, B. D., Ghazipura, M., Herman, D., Hon, S. M., Hossain, T., Kheir, F., Knight, S. L., Kreuter, M., Macrea, M. M., et al. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202102-172oc · Cited by 49
Self-citationIdiopathic Pulmonary Fibrosis (IPF) incidence and prevalence in Italy.
Agabiti, N., Porretta, M. A., Bauleo, L., Coppola, A., Sergiacomi, G., Fusco, A., Cavalli, F., Zappa, M. C., Vignarola, R., Carlone, S., et al. (2014) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 48
Janssen, K., Rosielle, D. A., Wang, Q., & Kim, H. J. (2020) · Respiratory Research · doi:10.1186/s12931-019-1266-9 · Cited by 47
OHNO, S., NAKAYA, T., BANDO, M., & SUGIYAMA, Y. (2008) · Respirology · doi:10.1111/j.1440-1843.2008.01349.x · Cited by 46
Diagnostic value of KL-6 in idiopathic interstitial pneumonia
Zheng, P., Liu, X., Huang, H., Guo, Z., Wu, G., Hu, H., Cai, C., Luo, W., Wei, N., Han, Q., et al. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.07.54 · Cited by 42
Moon, S. W., Kim, S. Y., Chung, M. P., Yoo, H., Jeong, S. H., Kim, D. S., Song, J. W., Lee, H. L., Choi, S. M., Kim, Y. W., et al. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202005-451oc · Cited by 40
Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis
Kärkkäinen, M., Nurmi, H., Kettunen, H.-P., Selander, T., Purokivi, M., & Kaarteenaho, R. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0642-4 · Cited by 38
The Mortality Burden of Idiopathic Pulmonary Fibrosis in the United Kingdom
Navaratnam, V. V., & Hubbard, R. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201902-0467le · Cited by 37
Cottin, V., Tomassetti, S., Valenzuela, C., Walsh, S. L. F., Antoniou, K. M., Bonella, F., Brown, K. K., Collard, H. R., Corte, T. J., Flaherty, K. R., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202111-2607pp · Cited by 37
Self-citationLasky, J. A., Case, A., Unterman, A., Kreuter, M., Scholand, M. B., Chaudhary, S., Lofaro, L. R., Johnson, M., Huang, J., Bhorade, S. M., et al. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202107-897oc · Cited by 34
Salciccioli, J. D., Marshall, D. C., Goodall, R. J., et al. (2022) · ERJ Open Research · doi:10.1183/23120541.00058-2022 · Cited by 34
Potential Delays in Diagnosis of Idiopathic Pulmonary Fibrosis in Medicare Beneficiaries
Mooney, J. J., Chang, E. Y., Lalla, D., Papoyan, E., Raimundo, K., Reddy, S. R., Stauffer, J. L., Yan, T., & Broder, M. S. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201806-376rl · Cited by 33
Farrand, E. D., Iribarren, C., Vittinghoff, E., Levine‐Hall, T., Ley, B., Minowada, G., & Collard, H. R. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.07.035 · Cited by 33
Scallan, C. J., Strand, L. N., Hayes, J., Kadura, S., Collins, B. F., Ho, L. A., Spada, C. A., Canestaro, W. J., Kolb, M. R. J., & Raghu, G. (2021) · European Respiratory Journal · doi:10.1183/13993003.00917-2021 · Cited by 30
Self-citationIncidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia
Cox, I. A., Otáhal, P., de Graaff, B., et al. (2021) · Respirology · doi:10.1111/resp.14194 · Cited by 30
Cluster analysis of transcriptomic datasets to identify endotypes of idiopathic pulmonary fibrosis
Kraven, L. M., Taylor, A. R., Molyneaux, P. L., Maher, T. M., McDonough, J. E., Mura, M., Yang, I. V., Schwartz, D. A., Huang, Y., Noth, I., et al. (2022) · Thorax · doi:10.1136/thoraxjnl-2021-218563 · Cited by 29
Gaffney, A. W., Steffie, W., Himmelstein, D. U., & McCormick, D. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3407-0 · Cited by 28
Molyneaux, P. L., Smith, J. J., Saunders, P. T., Chua, F., Wells, A. U., Renzoni, E. A., Nicholson, A. G., Fahy, W. A., Jenkins, G. R., & Maher, T. M. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202004-1138le · Cited by 28
Disparities in Rural Populations With Idiopathic Pulmonary Fibrosis
DeDent, A. M., Collard, H. R., & Thakur, N. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.03.042 · Cited by 26
Epidemiologic Analysis of Taiwanese Patients with Idiopathic Pulmonary Fibrosis
Yang, S., Perng, D., Ko, H., Chang, Y., Hsu, C.-C., Huang, H., & Chung, M. (2020) · Healthcare · doi:10.3390/healthcare8040580 · Cited by 18
Podolanczuk, A. J., Noth, I., & Raghu, G. (2021) · European Respiratory Journal · doi:10.1183/13993003.03551-2020 · Cited by 15
Self-citationThe Association between Exposures and Disease Characteristics in Familial Pulmonary Fibrosis
Copeland, C. R., Donnelly, E. F., Mehrad, M., Ding, G., Markin, C. R., Douglas, K., Wu, P., Cogan, J. D., Young, L. R., Bartholmai, B. J., et al. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202203-267oc · Cited by 15
Self-citationZhang, D., Li, Q., Povysil, G., Newton, C. A., Maher, T. M., Molyneaux, P. L., Noth, I., Martínez, F. J., Raghu, G., Todd, J. L., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202203-0622le · Cited by 13
Self-citationPROMising developments in IPF patient-reported outcome measures
Nolan, C. M., & Birring, S. S. (2022) · European Respiratory Journal · doi:10.1183/13993003.02312-2021 · Cited by 12
Pérez, E. R. F. (2019) · European Respiratory Journal · doi:10.1183/13993003.00364-2019 · Cited by 10
Anxiety and depression in idiopathic pulmonary fibrosis (IPF): prevalence and clinical correlates
Nolan, C. M., Patel, S., Barker, R. E., et al. (2017) · doi:10.1183/1393003.congress-2017.pa848 · Cited by 7
Research works printed but not linked: 1
- 10.1186/s12931-019 · doi:10.1186/s12931-019
Cited by
Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis
Bonella, F., Spagnolo, P., & Ryerson, C. (2023) · Drugs · doi:10.1007/s40265-023-01950-0 · Cited by 182
“Median survival time is 3–5 years after diagnosis without treatment [2], but recently published observations report improving survival over the last 2 decades, may be related to earlier diagnosis, and use of antifi-brotics [3, 4].”
BackgroundPulmonary fibrosis: pathogenesis and therapeutic strategies
Wang, J., Li, K., Hao, D., Li, X., Zhu, Y., Yu, H., & Chen, H. (2024) · MedComm · doi:10.1002/mco2.744 · Cited by 149
Spatial transcriptomic characterization of pathologic niches in IPF
Mayr, C. H., Santacruz, D., Jarosch, S., Bleck, M., Dalton, J., McNabola, A., Lempp, C., Neubert, L., Rath, B., Kamp, J. C., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl5473 · Cited by 146
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows
Chianese, M. I., Screm, G., Salton, F., Confalonieri, P., Trotta, L., Barbieri, M., Ruggero, L., Mari, M., Reccardini, N., Geri, P., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17060709 · Cited by 128
“…distortion may ultimately impact up to eleven percent of patients after hospitalization with COVID-19, support the need for validated treatment protocols to contrast the progression of lung alterations and the emerging consequences of the pandemic, especially in younger patients [61,99,100].”
BackgroundRaghu, G., Ghazipura, M., Fleming, T. R., Aronson, K. I., Behr, J., Brown, K. K., Flaherty, K. R., Kazerooni, E. A., Maher, T. M., Richeldi, L., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202312-2213so · Cited by 92
Self-citation
Metadata
- Authors
- Podolanczuk, A. J., Thomson, C. C., Remy-Jardin, M., Richeldi, L., Martinez, F. J., Kolb, M., & Raghu, G.
- Affiliations
- Weill Cornell Medicine (US)
- Mount Auburn Hospital (US)
- Università Cattolica del Sacro Cuore (IT)
- St. Joseph’s Healthcare Hamilton (CA)
- University of Washington (US)
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2023-01-26
- Volume
- 61
- Issue
- 4
- Pages
- 2200957
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W4318071623
- Cited by
- 359
- References
- 196
- Citations by year
- 2026: 112 · 2025: 126 · 2024: 101 · 2023: 20
- FWCI
- 65.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Respiratory Journal (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- idiopathic pulmonary fibrosis, antifibrotic therapy, lung function decline, disease progression, natural history (disease), pathobiology, genetic risk factors, comorbidities, patient monitoring, palliative care, lung transplantation, early detection, diagnosis
- MeSH terms
- Aged, Humans, Tomography, X-Ray Computed, Lung Transplantation, Disease Progression, Early Diagnosis, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.